In addition, our data show that foamy microglia upregulate several AD genetic risk factors, including cholesterol transporters Abca1, Apoc1 and Apoe59, further implicating them in the disease beyond the LPC demyelination model. This evidence concerns the gene APOC1 and Alzheimer disease.